MSD has acquired Yale University spinout Modifi Biosciences, claiming ownership of a potential new class of therapeutics for difficult-to-treat brain tumours, including glioblastomas. Under the terms ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

Discover the top 3 undervalued Automobile Components stocks for Tuesday, December 30 based on AAII’s Stock Grades.

According to Consumer Reports, 44% of people who checked their credit report found errors. More than a quarter (27%) found serious errors that could impact their score, such as accounts they didn't ...

Jason Fernando is a professional investor and writer who enjoys tackling and communicating complex business and financial problems. Natalya Yashina is a CPA, DASM with over 12 years of experience in ...